Fusion Fund

We’re excited to share that our CEO & Co-founder, John Yue, spoke on an insightful panel at HumanX in Las Vegas, exploring the evolving demands of AI infrastructure and the innovations needed to support its rapid growth. The conversation explored key challenges and opportunities, including the financial hurdles of scaling AI, the shift from training to inference, and the need for AI-native infrastructure. GPU virtualization and fractionalization emerged as essential solutions for maximizing efficiency, reducing costs, and improving accessibility. A huge thank you to HumanX, Ron Miller, César Maklary, and Roseanne Wincek for fostering these critical discussions and bringing together top minds in AI and tech. Stay tuned as we continue pushing the boundaries of what’s possible! Missed out? Watch the recorded discussion here: https://lnkd.in/gtV54G8u #AI #Infrastructure #FutureOfAI #HumanX #GPU #TechInnovation #Virtualization #Scalability #AICompute #NeedGPU

As an early-stage investor in?Proscia, Fusion Fund has supported the company’s journey from the beginning. We are proud to continue backing the team in?its?latest?$50M funding round, led by?Insight Partners, bringing Proscia’s total funding to?$130M. This investment will accelerate?its?mission to?transform AI-driven pathology?and advance the future of?precision medicine. Pathology underpins up to 70% of clinical decisions?and plays a critical role in every new drug brought to market. Yet, despite increasing case volume and a shrinking workforce, it remains one of the last fields in medicine to fully modernize. The healthcare industry—and the patients it serves—deserve better. At the center of this transformation is?Concentriq, Proscia’s?AI-driven pathology platform, which serves as a?foundation for the precision medicine value chain?by: ???Powering drug discovery?– Enabling researchers to develop novel therapies faster ??Accelerating diagnosis?– Enhancing pathologists' ability to analyze and interpret data efficiently ???Connecting life sciences organizations and labs?– Creating a network that helps match patients with the most targeted treatments This investment follows?record-breaking growth in 2024. Today,?16 of the top 20 pharmaceutical companies?use Proscia, and its Concentriq platform is on track to support?22,000+ patient diagnoses daily. Congrats to CEO David West and the entire Proscia Team! Great to be on this journey with you ?? Read more about this milestone: https://lnkd.in/g87w7wa8 #AI #HealthcareInnovation #DigitalPathology #VentureCapital

Jensen Huang’s keynote yesterday set the stage for a new era in AI, where digital intelligence and physical interaction combine to transform entire industries. At Fusion Fund, we share this vision. We believe physical AI is not only the next frontier but also a catalyst for a real-world productivity renaissance. Over the past few years, we’ve been investing in and researching the physical AI space. Advances in AI, edge computing, and simulation techniques are overcoming long-standing challenges like the data bottleneck, while domestic policies are driving increased productivity and re-industrialization. These trends are coming together to create safer, more efficient, and highly scalable autonomous systems. To share our insights and commitment to this transformative space, we’re excited to attach our Physical AI Industry Report. In the report, we cover market trends, key technology drivers, and our strategic investments, from companies like Starpath, SAIF Autonomy, and Blumind, that demonstrate how physical AI is poised to revolutionize sectors such as industrial automation, healthcare, and beyond. Read the report here:?https://lnkd.in/gYaZvHYE Huge shoutouts to Jim Fan at NVIDIA, Christoph Kohstall, PhD Kohstall at 1X, and many other experts who have shared their valuable insights on the transformation occurring in the physical AI space. Last but not least, thank you to Andrew Galbraith for your hard work and contributions.

Fusion Fund is excited to publish our #PhysicalAI Industry Report. This report, led by Ryan JB Taylor, dives deep into market trends, key technology drivers, and our strategic investments in the physical AI space. Jensen Huang’s keynote yesterday set the stage for a new era in AI, where digital intelligence and physical interaction combine to transform entire industries. At Fusion Fund, we share this vision. We believe physical AI is not only the next frontier but also a catalyst for a real-world productivity renaissance. Over the past few years, we’ve been investing in and researching the physical AI space. Advances in AI, edge computing, and simulation techniques are overcoming long-standing challenges like the data bottleneck, while domestic policies are driving increased productivity and re-industrialization. These trends are coming together to create safer, more efficient, and highly scalable autonomous systems. To share our insights and commitment to this transformative space, we’re excited to attach our Physical AI Industry Report, where we cover strategic investments in companies like Starpath Robotics, SAIF Autonomy, and Blumind—demonstrating how physical AI is poised to revolutionize sectors such as industrial automation, healthcare, and beyond. Read the report here: https://lnkd.in/gbQaGtAW Huge shoutouts to Jim Fan at NVIDIA, Christoph Kohstall, PhD at 1X, and many other experts who have shared their valuable insights on the transformation occurring in the physical AI space.

Stay humble and focus on delivering great stuff and positive changes for the American food supply industry: https://lnkd.in/gUaBryGz #buildgreatcompany #disruptfoodsupplychain #EnterpriseAI

Our portfolio company, GrubMarket Inc., has achieved a major milestone with the announcement of their $50M Series G at a $3.5B valuation. GrubMarket Inc. connects consumers with fresh, local produce through an online farmers market, transforming the food supply chain by leveraging AI and technology. This latest round of funding will help them advance their AI-driven solutions, which aim to streamline business operations and improve data management for food distributors. The funding will also support their continued growth and expansion into new markets globally. Congratulations to CEO and Founder Mike Xu and the entire GrubMarket Inc. team! Read more about the news below: https://lnkd.in/grGVyirJ

Great to see our Founder and Managing Partner, Lu Zhang, featured as a top investor to follow on LinkedIn.

Vectara’s Postman Collection is Here! Building GenAI applications just got easier. With Vectara’s Postman collection, developers can now seamlessly integrate with our Enterprise #RAG API—no complex setup, no boilerplate code, just powerful AI at your fingertips. ?? Quickly test API calls for document indexing, querying, and chat ?? Streamline workflows with re-rankers, contextual configurations, and factual consistency scoring ?? Experiment with real-time AI directly in Postman’s user-friendly interface ?? Read the blog: https://lnkd.in/gnr_pqx4 #Postman #Vectara #Partner #GenAI #RAGaaS #AIIntegration #APIs #DeveloperTools

A great way to close out Satellite 2025, and an interesting conversation reflecting a healthy mix of both traditional and new space thinking. Good to see the consistent support amongst the panelists for the importance of growing innovative companies that can actually close their business cases in the new space economy. Too many business cases in new space today simply don’t close - it’s high time (pun intended) that industry brings forth real, sustainable, profitable businesses.

Nimble Science is pleased to announce a partnership with KGK Science to re-imagine future biomarkers for GI health as Nimble's #SIMBACapsule state-of-the-art technology opens new avenues for how GI studies can be conducted in the future. “KGK Science is a leader in conducting clinical trials and helping companies gain market access and market distinction. We have vast experience in conducting clinical trials for probiotics and nutraceutical food ingredients with GI health outcomes over the past 28 years.” says Najla Guthrie , Chief Executive Officer at KGK Science. “By integrating Nimble Science’s revolutionary SIMBA? capsule technology, we can offer a state-of-the-art method for evaluating GI health outcomes in clinical trials, reducing the need for invasive biopsies”. “Nimble Science aims to be the leading global collaborator in delivering actionable intelligence from the GI tract. Our SIMBA? platform and capsule technology is transformative for conducting clinical trials in #GIhealth,” added Dr. Sabina Bruehlmann, CEO of Nimble Science. “This partnership with KGK Science is a major step toward our goal to transform global markets related to GI health research.” Learn more today: www.nimblesci.com Read more: https://lnkd.in/dbNpQ37F Get started: ?? Website: www.kgkscience.com ?? Email: [email protected] ?? Phone #: +1 519 438 9374 ?? Website: www.nimblesci.com ?? Email: [email protected] #ClinicalResearch #GIHealth #Nutraceuticals #Probiotics #Innovation #KGKScience #NimbleScience